Amivantamab plus chemo is now indicated in locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R ...

Lung cancer is one of the most common and aggressive cancers. Its most characteristic symptoms include coughing, shortness of ...

Bengaluru: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Durvalumab 120 ...

Lung cancer is one of the most common and aggressive cancers. Its most characteristic symptoms include coughing, shortness of ...

Combining screening for lung and kidney cancers – for both of which smoking is a risk factor – could help identify ...

A race-neutral algorithm for lung function was recommended last year. Adopting it comes with thorny consequences.

New anecdotal evidence suggests some chemoimmunotherapy treatments may improve pulmonary arterial hypertension symptoms, but the overall evidence remains murky.

According to GLOBOCAN 2022 data, lung cancer remains the fourth most common cause of cancer-related mortality in India.

This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.

About 40% of Americans will develop a form of cancer at some point in their lifetime, according to the American Cancer ...

AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...